- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Allison F. Kassir
News 7 results
In the News · Source: Modern Healthcare
November 6, 2024
Allison Kassir discusses potential changes to healthcare policies during President-elect Trump’s term
Recognition
October 29, 2024
National Institute for Lobbying & Ethics Again Recognizes Allison Kassir as a Top Lobbyist
Recognition
November 15, 2023
National Institute for Lobbying & Ethics Names Allison Kassir a Top Lobbyist
Events 24 results
Conference
March 17, 2025
34th Annual King & Spalding Health Law & Policy Forum
Webinar
February 13, 2025
Impact of the 2024 Election on Pharmaceutical, Biologics and Device Manufacturers
Webinar
December 18, 2024
Changed Landscape? How 2024 Elections Will Impact Healthcare M&A
Conference
September 30, 2024
Annual Health Law & Policy Forum West
Insights 51 results
Client Alert
June 5, 2025
Administrative, Congressional, and State Interest Signal a Potential Breakthrough Moment for Psychedelics
Newsletter
May 27, 2025
Health Headlines – May 27, 2025
Newsletter
May 19, 2025
Health Headlines – May 19, 2025
Client Alert
March 12, 2024
A Brief Overview of the Federal Rulemaking Process in the United States